https://www.selleckchem.com/pr....oducts/ziritaxestat.
05), perineural invasion (p less then 0.01), stage III (p less then 0.05) and high-grade tumor (p less then 0.05). Conclusions This retrospective pilot study of a single-center cohort of patients with stage II and III colorectal cancer highlights the clinical importance of using immunohistochemistry (IHC) analysis as a guide for diagnostic algorithm in a country with limited resources, but with a high prevalence of colorectal carcinoma in the young patients. MMR-deficiency tumors compared with proficient MMR colorectal cancer was n
Like
Comment
Share
